{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:56:03Z","timestamp":1791701763192,"version":"4.3.4"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100005632","name":"Forest Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The efficacy of oral pharmacotherapy for erectile dysfunction (ED) (i.e., type 5 phosphodiesterase [PDE5] inhibitors) is significantly reduced in diabetic patients. Nebivolol is a selective \u03b21-blocker used for treating hypertension that has been shown to increase the efficacy of sildenafil to reverse ED in diabetic rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate the effects of nebivolol on the efficacy of the PDE5 inhibitors, sildenafil, tadalafil, and vardenafil to relax human corpus cavernosum (HCC) and vasodilate human penile resistance arteries (HPRA) from diabetic patients with ED (DMED). The influence of nebivolol on the capacity of these three PDE5 inhibitors to stimulate cyclic guanosine monophosphate (cGMP) production in HCC was also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>HCC and HPRA were obtained from organ donors without ED (NEND; n = 18) or patients with diabetes undergoing penile prosthesis implantation (DMED; n = 19). Relaxations of HCC strips and HPRA to sildenafil, tadalafil, and vardenafil were evaluated in organ chambers and wire myographs. cGMP content in HCC was determined by ether extraction and quantification by ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Effects of nebivolol on PDE5 inhibitor-induced relaxation of HCC, vasodilation of HPRA and cGMP accumulation in HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Treatment with nebivolol (1 \u03bcM) significantly potentiated sildenafil-, tadalafil- and vardenafil-induced relaxations of HCC and vasodilations of HPRA from both NEND and DMED. Enhancement of relaxant capacity by nebivolol resulted in reversion of the impairment of PDE5 inhibition-induced responses in DMED and it was accompanied by enhancing the ability of PDE5 inhibitors to increase cGMP in HCC restoring reduced cGMP levels in HCC from DMED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nebivolol potentiated the capacity of PDE5 inhibitors to relax vascular structures of erectile tissue from diabetic patients by enhancing the nitric oxide (NO)\/cGMP pathway in these tissues. These effects suggest a potential therapeutic utility of nebivolol as an adjunct to PDE5 inhibitors for the treatment of ED associated with diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jsm.12477","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T13:10:40Z","timestamp":1392901840000},"page":"1182-1192","source":"Crossref","is-referenced-by-count":25,"title":["Nebivolol Potentiates the Efficacy of PDE5 Inhibitors to Relax Corpus Cavernosum and Penile Arteries from Diabetic Patients by Enhancing the NO\/cGMP Pathway"],"prefix":"10.1093","volume":"11","author":[{"given":"Juan I.","family":"Mart\u00ednez-Salamanca","sequence":"first","affiliation":[{"name":"Servicio de Urolog\u00eda \u00a0 , Madrid , Spain"},{"name":"Hospital Universitario Puerta de Hierro \u00a0 , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"La Fuente","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Urologia \u00a0 , Porto , Portugal"},{"name":"Hospital Santo Antonio \u00a0 , Porto , Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Urologia \u00a0 , Lisboa , Portugal"},{"name":"Hospital Amadora-Sintra \u00a0 , Lisboa , Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argentina","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Servicio de Histolog\u00eda-Investigaci\u00f3n \u00a0 \u00a0 , Madrid , Spain"},{"name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria \u00a0 \u00a0 , Madrid , Spain"},{"name":"Hospital Universitario Ram\u00f3n y Cajal \u00a0 \u00a0 , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Cuevas","sequence":"additional","affiliation":[{"name":"Servicio de Histolog\u00eda-Investigaci\u00f3n \u00a0 \u00a0 , Madrid , Spain"},{"name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria \u00a0 \u00a0 , Madrid , Spain"},{"name":"Hospital Universitario Ram\u00f3n y Cajal \u00a0 \u00a0 , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold M.","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Pharmacology \u00a0 , Jersey City, NJ , Italy"},{"name":"Forest Research Institute \u00a0 , Jersey City, NJ , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Angulo","sequence":"additional","affiliation":[{"name":"Servicio de Histolog\u00eda-Investigaci\u00f3n \u00a0 \u00a0 , Madrid , Spain"},{"name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria \u00a0 \u00a0 , Madrid , Spain"},{"name":"Hospital Universitario Ram\u00f3n y Cajal \u00a0 \u00a0 , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"key":"2024032602352803800_bib1","first-page":"H1590","article-title":"Trabecular smooth muscle modulates the capacitor function of the penis: Studies on a rabbit model","volume":"260","author":"S\u00e1enz de Tejada","year":"1991","journal-title":"Am J Physiol"},{"key":"2024032602352803800_bib2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0006-291X(90)92168-Y","article-title":"Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle","volume":"170","author":"Ignarro","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2024032602352803800_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI115266","article-title":"A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle","volume":"88","author":"Kim","year":"1991","journal-title":"J Clin Invest"},{"key":"2024032602352803800_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1743-6109.2009.01624.x","article-title":"Anatomy, physiology, and pathophysiology of erectile dysfunction","volume":"7","author":"Gratzke","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602352803800_bib5","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1743-6109.2008.01168.x","article-title":"Erectile dysfunction in diabetes mellitus","volume":"6","author":"Malavige","year":"2009","journal-title":"J Sex Med"},{"key":"2024032602352803800_bib6","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.2337\/dc12-2109","article-title":"The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: A 23-year follow-up of the diabetes control and complications\/epidemiology of diabetes interventions and complications cohort","volume":"36","author":"Jacobson","year":"2013","journal-title":"Diabetes Care"},{"key":"2024032602352803800_bib7","doi-asserted-by":"crossref","first-page":"e43673","DOI":"10.1371\/journal.pone.0043673","article-title":"Erectile dysfunction and cardiovascular events in diabetic men: A meta-analysis of observational studies","volume":"7","author":"Yamada","year":"2012","journal-title":"PLoS ONE"},{"key":"2024032602352803800_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ahj.2012.04.006","article-title":"Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes","volume":"164","author":"Miner","year":"2012","journal-title":"Am Heart J"},{"key":"2024032602352803800_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.ijir.3900910","article-title":"Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus","volume":"14","author":"Vickers","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032602352803800_bib10","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s00125-004-1549-6","article-title":"Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: Analysis of data from tadalafil clinical trials","volume":"47","author":"Fonseca","year":"2004","journal-title":"Diabetologia"},{"key":"2024032602352803800_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1755-5922.2008.00054.x","article-title":"Nebivolol: A highly selective \u03b21-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide","volume":"26","author":"Gupta","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"2024032602352803800_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.coph.2012.12.002","article-title":"Beta blockers, nitric oxide, and cardiovascular disease","volume":"13","author":"Vanhoutte","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"2024032602352803800_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1755-5922.2009.00123.x","article-title":"Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents","volume":"28","author":"Cordero","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"2024032602352803800_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-1241.2010.02563.x","article-title":"Cardiovascular risk, drugs and erectile function\u2014A systematic analysis","volume":"65","author":"Baumh\u00e4kel","year":"2011","journal-title":"Int J Clin Pract"},{"key":"2024032602352803800_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1440-1681.2007.04551.x","article-title":"Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): Benefit of nebivolol versus metoprolol in hypertensive men","volume":"34","author":"Brixius","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2024032602352803800_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00044011-200525060-00006","article-title":"Randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men","volume":"25","author":"Boydak","year":"2005","journal-title":"Clin Drug Investig"},{"key":"2024032602352803800_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1745-7262.2006.00076.x","article-title":"Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients","volume":"8","author":"Doumas","year":"2006","journal-title":"Asian J Androl"},{"key":"2024032602352803800_bib18","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIR.0b013e3182447787","article-title":"Sexual activity and cardiovascular disease: A scientific statement from the American Heart Association","volume":"125","author":"Levine","year":"2012","journal-title":"Circulation"},{"key":"2024032602352803800_bib19","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.amjhyper.2006.05.016","article-title":"In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats","volume":"19","author":"Toblli","year":"2006","journal-title":"Am J Hypertens"},{"key":"2024032602352803800_bib20","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.lfs.2007.04.016","article-title":"Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum","volume":"80","author":"Reidenbach","year":"2007","journal-title":"Life Sci"},{"key":"2024032602352803800_bib21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/jpet.107.135681","article-title":"Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice","volume":"325","author":"Baumh\u00e4kel","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"2024032602352803800_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1743-6109.2009.01587.x","article-title":"Diabetes exacerbates the functional deficiency of NO\/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries","volume":"7","author":"Angulo","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602352803800_bib23","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1111\/j.1743-6109.2010.01710.x","article-title":"Nebivolol dilates penile arteries and reverses erectile dysfunction in diabetic rats through enhancement of nitric oxide signaling","volume":"7","author":"Angulo","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602352803800_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bph.12143","article-title":"Ca2+-activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetes","volume":"169","author":"Gonz\u00e1lez-Corrochano","year":"2013","journal-title":"Br J Pharmacol"},{"key":"2024032602352803800_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small resistance arteries in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ Res"},{"key":"2024032602352803800_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"2024032602352803800_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"key":"2024032602352803800_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1517\/14656566.9.2.257","article-title":"Treatment strategies for diabetic patients suffering from erectile dysfunction","volume":"9","author":"Chen","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"2024032602352803800_bib29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.eururo.2013.01.012","article-title":"Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: A systematic review and network meta-analysis","volume":"63","author":"Yuan","year":"2013","journal-title":"Eur Urol"},{"key":"2024032602352803800_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.281.5.421","article-title":"Sildenafil for treatment of erectile dysfunction in men with diabetes. A randomized controlled trial","volume":"281","author":"Rendell","year":"1999","journal-title":"JAMA"},{"key":"2024032602352803800_bib31","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/diacare.25.12.2159","article-title":"Effects of tadalafil on erectile dysfunction in men with diabetes","volume":"25","author":"S\u00e1enz de Tejada","year":"2002","journal-title":"Diabetes Care"},{"key":"2024032602352803800_bib32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/diacare.26.3.777","article-title":"Vardenafil a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter double-blind placebo-controlled fixed-dose study","volume":"26","author":"Goldstein","year":"2003","journal-title":"Diabetes Care"},{"key":"2024032602352803800_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.mayocp.2012.06.016","article-title":"Avanafil for the treatment of erectile dysfunction: A multicenter, randomized, double-blind study in men with diabetes mellitus","volume":"87","author":"Goldstein","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"2024032602352803800_bib34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jsm.12095","article-title":"Synergistic effects of BAY 60\u20134552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure","volume":"10","author":"Albersen","year":"2013","journal-title":"J Sex Med"},{"key":"2024032602352803800_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/FJC.0b013e3180587e35","article-title":"Vasodilator effects of nebivolol in a rat model of hypertension and a rabbit model of congestive heart failure","volume":"50","author":"De Groot","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"2024032602352803800_bib36","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)10549-1","article-title":"Nebivolol vasodilates human forearm vasculature: Evidence for an L-arginine\/NO dependent mechanism","volume":"274","author":"Cockcroft","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"2024032602352803800_bib37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1365-2125.1999.00037.x","article-title":"The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension","volume":"48","author":"Dawes","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"2024032602352803800_bib38","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ajh.2009.163","article-title":"Loss of arterial and nitric oxide bioavailability in hypertensive rats with diabetes: Effect of beta-blockers","volume":"22","author":"Mason","year":"2009","journal-title":"Am J Hypertens"},{"key":"2024032602352803800_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1742-7843.2012.00911.x","article-title":"Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension","volume":"111","author":"Zepeda","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2024032602352803800_bib40","doi-asserted-by":"crossref","first-page":"F775","DOI":"10.1152\/ajprenal.00233.2012","article-title":"Nebivolol-induced vasodilation of renal afferent arterioles involves \u03b23-adrenergic receptor and nitric oxide synthase activation","volume":"303","author":"Feng","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"2024032602352803800_bib41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/liv.12101","article-title":"Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signaling","volume":"33","author":"Reiberger","year":"2013","journal-title":"Liver Int"},{"key":"2024032602352803800_bib42","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.jacc.2011.09.033","article-title":"Beta3-adrenoceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation","volume":"58","author":"Arag\u00f3n","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2024032602352803800_bib43","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ajh.2008.260","article-title":"Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients","volume":"21","author":"Pasini","year":"2008","journal-title":"Am J Hypertens"},{"key":"2024032602352803800_bib44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.ATV.0000065234.70518.26","article-title":"Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells","volume":"23","author":"Mollnau","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024032602352803800_bib45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.HYP.0000239207.82326.29","article-title":"Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats","volume":"48","author":"Oelze","year":"2006","journal-title":"Hypertension"},{"key":"2024032602352803800_bib46","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.CIR.102.6.677","article-title":"Nebivolol: A third-generation beta-blocker that augments vascular nitric oxide release: Endothelial beta2-adrenergic receptor-mediated nitric oxide production","volume":"102","author":"Broeders","year":"2000","journal-title":"Circulation"},{"key":"2024032602352803800_bib47","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCULATIONAHA.104.532960","article-title":"Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol","volume":"112","author":"Dessy","year":"2005","journal-title":"Circulation"},{"key":"2024032602352803800_bib48"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515307700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515307700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/5\/1182\/48358717\/jsm_11_5_1182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/5\/1182\/48358717\/jsm_11_5_1182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:09:11Z","timestamp":1746122951000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/11\/5\/1182\/6958067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,1]]},"published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12477","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,5]]},"published":{"date-parts":[[2014,5,1]]}}}